B&L Looks To TV, Equipment Financing To Spur Zyoptix Wavefront LASIK Use
This article was originally published in The Gray Sheet
Executive Summary
Bausch & Lomb will launch a TV ad campaign for the Zyoptix custom wavefront ablation system upon FDA approval by year-end, Senior VP and CFO Stephen McCluski said at the Bear Stearns annual healthcare conference in New York Sept. 9
You may also be interested in...
Bausch & Lomb, Ciba Settlement Leaves No Outstanding Suits Between Firms
Bausch & Lomb will pay royalties on U.S. PureVision contact lens sales until 2014 under the terms of a silicone hydrogel technology cross-license with competitor Novartis/Ciba Vision
Bausch & Lomb, Ciba Settlement Leaves No Outstanding Suits Between Firms
Bausch & Lomb will pay royalties on U.S. PureVision contact lens sales until 2014 under the terms of a silicone hydrogel technology cross-license with competitor Novartis/Ciba Vision
J&J’s Acuvue One-Day Contact Lens Challenged By Bausch & Lomb In Japan
Bausch & Lomb will launch its Soflens one-day disposable contact lenses in Japan next year, having earned October regulatory approval